Miruvor
Sign up
ME/CFS Outcome unclear

ME/CFS: MOTS-c worth trying before NAD+, start low

Condition
ME/CFS
At worst
Not stated
Ill for
Not stated
Last post
Jun 2026
In their words
  • Condition: ME/CFSMOTS-c is worth trying before NAD+ for ME/CFS specifically In context ↗
Read from 1 of their posts and comments; links to the one this page draws on

Request to remove this story

Summary

A person reported trying MOTS-c from Next Level Pharm and said they did not hit the hard wall that some people experience with NAD+ precursors, which they linked to methylation issues. They called MOTS-c worth trying before NAD+ for ME/CFS specifically and advised starting low regardless.

Ask Miruvor AI

Asking aboutSequoia 55380’s story

What they tried

Also tried

Their words about each treatment
  • MOTS-c · Not saidI tried next level pharm for MOTS-c and didn't hit that wall.start low regardless. In context ↗

Ask Miruvor AI

Asking aboutSequoia 55380’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime